Updated: January 13, 2026
Phyrago Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- Category 1: Strong CYP3A4 Inhibitors — Increase Phyrago Levels
- Category 2: Strong CYP3A4 Inducers — Decrease Phyrago Levels
- Category 3: QT-Prolonging Drugs — Increased Cardiac Risk
- Category 4: Antacids — A Phyrago-Specific Consideration
- Category 5: Grapefruit and Grapefruit Juice
- Category 6: Anticoagulants and Antiplatelet Drugs
- What to Tell Your Doctor Before Starting Phyrago
Phyrago (dasatinib) has important interactions with CYP3A4 drugs, QT-prolonging medications, antacids, and grapefruit. Here's what to avoid and what to tell your doctor.
Phyrago (dasatinib) is a powerful targeted cancer therapy that can interact with many other medications. Some interactions can reduce its effectiveness, others can increase it to dangerous levels, and some can cause life-threatening complications. Before starting Phyrago, your oncologist needs a complete list of every medication, supplement, and over-the-counter drug you take.
This guide covers the most important Phyrago drug interactions and provides practical guidance on what to disclose and what to avoid.
Category 1: Strong CYP3A4 Inhibitors — Increase Phyrago Levels
Phyrago is metabolized primarily by the liver enzyme CYP3A4. Drugs that strongly inhibit CYP3A4 reduce Phyrago's breakdown, causing dasatinib to accumulate in the blood at higher-than-intended levels. This increases the risk of side effects including myelosuppression, QT prolongation, and bleeding.
Strong CYP3A4 inhibitors to avoid or use with caution:
Antifungals: ketoconazole, itraconazole, voriconazole, posaconazole
Antibiotics: clarithromycin, telithromycin
HIV medications: ritonavir, cobicistat, indinavir, nelfinavir, saquinavir, atazanavir, lopinavir/ritonavir
Other: conivaptan, lefamulin
Action: Avoid these medications if possible. If you must take a strong CYP3A4 inhibitor, your oncologist may reduce your Phyrago dose significantly (e.g., from 100 mg to 20 mg daily) and monitor you closely.
Category 2: Strong CYP3A4 Inducers — Decrease Phyrago Levels
CYP3A4 inducers speed up Phyrago's metabolism, reducing dasatinib blood levels and potentially allowing your leukemia to progress unchecked.
Strong CYP3A4 inducers to avoid:
Antibiotics: rifampin (rifampicin)
Seizure medications: carbamazepine, phenytoin, phenobarbital
Prostate cancer medications: apalutamide, enzalutamide
Herbal supplements: St. John's Wort (a commonly used herbal supplement for depression that is a potent CYP3A4 inducer — it can reduce dasatinib levels significantly)
Action: Avoid these if at all possible. If coadministration is unavoidable, your oncologist may increase your Phyrago dose and monitor you more closely.
Category 3: QT-Prolonging Drugs — Increased Cardiac Risk
Phyrago itself can cause QT interval prolongation — a change in the heart's electrical cycle that can lead to dangerous arrhythmias. Taking Phyrago with other QT-prolonging drugs multiplies this risk. Common QT-prolonging medications include:
Antipsychotics: haloperidol, olanzapine, quetiapine, ziprasidone, amisulpride
Anti-nausea medications: ondansetron (Zofran)
Certain antibiotics: azithromycin, moxifloxacin, levofloxacin
Antiarrhythmics: amiodarone, sotalol, dronedarone
Action: Use with caution. Your oncologist may require ECG monitoring if you must take these medications with Phyrago.
Category 4: Antacids — A Phyrago-Specific Consideration
This is where Phyrago differs significantly from standard dasatinib. Standard dasatinib should not be taken with PPIs or H2RAs because they reduce its absorption by 40–60%. However, Phyrago's novel formulation is not significantly affected by PPIs (like omeprazole or pantoprazole) or H2RAs (like famotidine).
However, aluminum or magnesium-containing antacids (like Tums, Rolaids, or Maalox) can still reduce Phyrago's absorption. These should be taken at least 2 hours before or after Phyrago.
Category 5: Grapefruit and Grapefruit Juice
Grapefruit and grapefruit juice are natural CYP3A4 inhibitors. They can increase dasatinib levels in the blood, raising the risk of side effects. Avoid grapefruit and grapefruit juice throughout your Phyrago treatment.
Category 6: Anticoagulants and Antiplatelet Drugs
Since Phyrago can cause thrombocytopenia (low platelet counts) and platelet dysfunction, adding anticoagulants or antiplatelet drugs significantly increases bleeding risk. Use with caution: warfarin, apixaban, rivaroxaban, heparin, aspirin (especially at higher doses), clopidogrel.
What to Tell Your Doctor Before Starting Phyrago
Tell your oncologist about all of the following:
Every prescription medication, including medications for other conditions
All over-the-counter medications, including antacids, NSAIDs, and aspirin
All vitamins and herbal supplements (especially St. John's Wort)
Any history of QT prolongation, arrhythmia, or heart disease
Also see our guide to Phyrago side effects. If you need help filling your prescription, visit medfinder.com.
Frequently Asked Questions
Major Phyrago interactions include: strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) which increase dasatinib levels; strong CYP3A4 inducers (rifampin, carbamazepine, apalutamide, St. John's Wort) which decrease levels; QT-prolonging drugs (antipsychotics, certain antibiotics, antiarrhythmics); aluminum/magnesium antacids; and anticoagulants. Grapefruit juice should also be avoided.
Yes — this is one of Phyrago's key advantages over standard dasatinib. Phyrago's novel formulation maintains full bioavailability when taken with proton pump inhibitors (PPIs) like omeprazole, pantoprazole, and esomeprazole, or H2 receptor antagonists like famotidine. Standard dasatinib (Sprycel or generic) loses 40–60% effectiveness with these medications.
Aluminum or magnesium-containing antacids (Tums, Rolaids, Maalox) can still reduce Phyrago's absorption and should be taken at least 2 hours before or 2 hours after your Phyrago dose. Note that PPIs and H2 receptor antagonists do NOT significantly affect Phyrago absorption — this is different from standard dasatinib.
No. Grapefruit and grapefruit juice inhibit CYP3A4, the enzyme that breaks down dasatinib. This can cause dasatinib levels to rise to potentially toxic levels. Avoid all grapefruit products throughout your Phyrago treatment.
Yes — significantly. St. John's Wort is a strong CYP3A4 inducer that can reduce Phyrago's blood levels substantially, potentially allowing your leukemia to progress. Avoid St. John's Wort entirely while taking Phyrago. Tell your oncologist if you are using it or any other herbal supplement.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Phyrago also looked for:
More about Phyrago
36,651 have already found their meds with Medfinder.
Start your search today.





